Gadopentetate dimeglumine (Alvogen, Inc)


Welcome to the PulseAid listing for the Gadopentetate dimeglumine drug offered from Alvogen, Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Alvogen, Inc
NON-PROPRIETARY NAME: Gadopentetate dimeglumine
SUBSTANCE NAME: GADOPENTETATE DIMEGLUMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2014-02-24
END MARKETING DATE: 0000-00-00


Gadopentetate dimeglumine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGadopentetate dimeglumine from Alvogen, Inc
LABELER NAME: Alvogen, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 469.01(mg/mL)
START MARKETING DATE: 2014-02-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 47781-147_1d137c2c-fd59-4203-8115-b0a25a282bef
PRODUCT NDC: 47781-147
APPLICATION NUMBER: NDA019596

Other GADOPENTETATE DIMEGLUMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen, IncGadopentetate dimeglumine
Bayer HealthCare Pharmaceuticals Inc.Magnevist